COLLEEN FARLEY: Open Payments
NPI 1598444747 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $175 |
| Teva Pharmaceuticals USA, Inc. | 3 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $42 |
| Biogen, Inc. | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: COBENFY, REXULTI, UZEDY, TRINTELLIX, ZURZUVAE, INGREZZA, AUSTEDO XR.
Industry payments across MA — which companies pay providers there.
